BUZZ-Hikma: back near record highs, top-ranked brokers come out in favour
** Hikma Pharmaceuticals (LSE: HIK.L - news) , up 3.7 pct and close to testing all-time high again after two 5-star rated brokers issue bullish recommendations on stock.
** Stock is Europe's best performing small-cap, extends 2014's stellar run that saw stock up 66.8 pct.
** JPMorgan lifts its PT on stock by 18.4 pct, keeps "overweight" rating, while Jefferies upgrades stock to a "buy"
** Jefferies expects momentum to continue into 2015 and expects company to prevail in ongoing legal case vs Takeda over co's respective gout treatment drugs.
** Hikma currently trading at 22.7 times forward earnings, a third above its historical median since listing in 2006. (RM (LSE: RM.L - news) : vikram.subhedar.thomsonreuters.com@reuters.net)